is peptide sciences semaglutide safe of the Week: Peptide: A Promising Advancement in Diabetes Treatment 1.5mg semaglutide GLP-1 S 5mg

Among patients on weekly GLP-1/GIP medications, the proportion of patients without clinically significant RGV was significantly higher in those who held the medication for more than 3 days (38 patients [92.7%]) compared with 3 days or less (5 patients [62.5%]) ( P = .047)

They quit

SGLT-2, sodium-glucose cotransporter-2

She conducts research on how patients access care, and those who are uncomfortable with digital tools like using apps and emailing their doctors are not receiving the same level of care and the same access to popular new weight loss drugs as those who are tech savvy and comfortable advocating for themselves

Working with a dietitian to increase daily protein and iron-rich foods

10.1111/jcmm.16325 J